Skip to main content

Client News

Topas Therapeutics Appoints Klaus Martin, Ph.D. as Chief Executive Officer

19th October 2020

CENTOGENE GmbH: Kooperation zwischen CENTOGENE und U-Diagnostics verstärkt COVID-19 Testkapazitäten in den Niederlanden

15th October 2020

CENTOGENE GmbH: Collaboration Between CENTOGENE and U-Diagnostics Increases COVID-19 Testing Capacities in the Netherlands Information Security Management System Awarded ISO/IEC 27001:2017 Accreditation

14th October 2020

Rentschler Biopharma SE: Rentschler Biopharma and ATUM announce Leap-In Transposase® licensing agreement for development of robust manufacturing processes for complex therapeutic proteins

14th October 2020

France Biotech: HealthTech For Care and EIT Health Announce the Success of the HealthTech Innovation Days’ Second Edition

14th October 2020

Apogenix Advances Clinical Development of CD95L Inhibitor Asunercept in European COVID-19 Phase II Trial

13th October 2020

Verona Pharma plc: Verona Pharma to Present Phase 2b COPD Symptom and Quality of Life Data with Ensifentrine at CHEST 2020

13th October 2020

Abivax secures EUR 15m non-dilutive financing from Kreos Capital

13th October 2020

Secarna Pharmaceuticals and Denali Therapeutics enter into research and option agreement to develop novel antisense therapies in the field of neurodegenerative diseases

13th October 2020

Rentschler Biopharma SE: Joining forces against SARS-CoV-2: Rentschler Biopharma contributes to manufacturing of COVID-19 mRNA vaccine

8th October 2020